Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook and Demand Growth Across 2026–2030

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Over The 2026–2030 Period?

The minimally invasive glaucoma surgery (migs) devices market size has experienced rapid expansion in recent years. It is projected to expand from $0.89 billion in 2025 to $1.14 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 28.1%. This historical growth can be ascribed to factors such as the increasing prevalence of glaucoma, a growing aging population, the limitations inherent in conventional glaucoma surgeries, heightened awareness regarding vision preservation, and the rising adoption of cataract surgeries.

The minimally invasive glaucoma surgery (migs) devices market size is anticipated to experience significant expansion over the coming years, with projections indicating a rise to $2.79 billion by 2030, driven by a compound annual growth rate (CAGR) of 24.9%. This projected growth throughout the forecast period stems from factors such as an enlarging glaucoma patient population, increased embrace of minimally invasive surgical alternatives, a surging demand for outpatient ophthalmic interventions, a heightened focus on patient quality-of-life outcomes, and improved access to specialized ophthalmology clinics. Noteworthy trends expected in this timeframe include the increasing uptake of minimally invasive glaucoma procedures, a growing inclination towards MIGS for early and moderate glaucoma cases, the expanding practice of combining MIGS with cataract surgery, an increase in outpatient and ambulatory glaucoma surgeries, and a sustained demand for glaucoma treatments offering enhanced safety and quicker recovery.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp

Which Major Factors Are Driving The Expansion Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

The rising occurrence of eye conditions is anticipated to drive the expansion of the minimally invasive glaucoma surgery (MIGS) devices market in the future. These conditions refer to numerous ailments impacting ocular health and sight. Their prevalence is on the rise, attributed to evolving lifestyle habits, environmental factors, and an aging demographic. Minimally invasive glaucoma surgery (MIGS) devices represent advanced instruments employed in treating diverse ocular diseases, with a primary goal of lowering intraocular pressure (IOP) to impede or manage glaucoma’s advancement. For illustration, data from 2024, provided by the National Eye Institute, a US-based government agency, indicates that approximately 2.2 million Americans are projected to experience blindness or partial vision loss by 2030. Consequently, the growing incidence of eye disorders significantly propels the minimally invasive glaucoma surgery (MIGS) devices market.

How Is The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmented Across Key Categories?

The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –

1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices

2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures

3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space

4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS

5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals

Subsegments:

1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents

2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts

3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents

4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices

Which Upcoming Trends Are Expected To Influence The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

Key players within the minimally invasive glaucoma surgery (MIGS) devices market are concentrating their efforts on creating sophisticated solutions, like sustained-release drug-delivery implants, designed to supersede conventional topical glaucoma therapies. Such an implant is defined as a mechanism that administers medication without interruption over an extended period, leading to better patient compliance, fewer required doses, and more effective treatment outcomes. As an example, in February 2024, Celanese Corporation, a US-based specialty materials firm, collaborated with Glaukos for the commercial introduction of the iDose® TR (Travoprost Intracameral Implant), leveraging Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This groundbreaking product supersedes conventional eye-drop routines by ensuring a constant intraocular supply of travoprost straight into the eye for an duration of multiple months. Incorporated into Glaukos’ MIGS product range, it presents a therapeutic choice that is minimally invasive, lessening the necessity for daily eye drops, boosting patient adherence, and facilitating consistent intraocular pressure management, which ultimately betters long-term treatment results.

Who Are The Dominant Players Shaping The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Landscape?

Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International

Read the full minimally invasive glaucoma surgery (migs) devices market report here:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Which Region Currently Holds The Largest Share Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2026, By The Business Research Company

Glaucoma Surgery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Cataract Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cataract-surgery-devices-and-equipment-global-market-report

Ophthalmic Handheld Surgical Instruments Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-handheld-surgical-instruments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model